Aflibercept

Details

Files
Generic Name:
Aflibercept
Project Status:
Complete
Therapeutic Area:
Macular edema, diabetic
Manufacturer:
Bayer Inc.
Call for patient/clinician input open:
Brand Name:
Eylea
Project Line:
Reimbursement Review
Project Number:
SR0396-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Performance Metric:
Not achieved
Submission Type:
Initial
Indications:
Macular edema, diabetic
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: